Antioxidant activities for superoxide dismutase in patients with Crohn’s disease

References

1. Cotran RS, Kumar V, Collins T. Robbins pathologic basis of disease. Philadelphia: W.B. Saunders Company, 1999.Suche in Google Scholar

2. Sartor RB. Microbial influences in inflammatory bowel diseases. Gastroenterology 2008;134:577–94.10.1053/j.gastro.2007.11.059Suche in Google Scholar

3. Scanlan PD, Marchesi JR. Micro-eukaryotic diversity of the human distal gut microbiota: qualitative assessment using culture-dependent and independent analysis of faeces. ISME J 2008;2:1183–93.10.1038/ismej.2008.76Suche in Google Scholar

4. Kühbacher T, Ott SJ, Helwig U, Mimura T, Rizzello F, Kleessen B, et al. Bacterial and fungal microbiota in relation to probiotic therapy (VSL#3) in pouchitis. Gut 2006;55:833–41.10.1136/gut.2005.078303Suche in Google Scholar

5. Frank DN, St Amand AL, Feldman RA, Boedeker EC, Harpaz N, Pace NR. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci USA 2007;104:13780–5.10.1073/pnas.0706625104Suche in Google Scholar

6. Ott SJ, Kühbacher T, Musfeldt M, Rosenstiel P, Hellmig S, Rehman A. Fungi and inflammatory bowel diseases: alterations of composition and diversity. Scand J Gastroenterol 2008;43:831–41.10.1080/00365520801935434Suche in Google Scholar

7. Fava F, Danese S. Intestinal microbiota in inflammatory bowel disease: friend of foe? World J Gastroenterol 2011;17:557–66.10.3748/wjg.v17.i5.557Suche in Google Scholar

8. Colon AL, Madrigal JL, Menchen LA, Moro MA, Lizasoain I, Lorenzo P, et al. Stress increases susceptibility to oxidative/nitrosative mucosal damage in an experimental model of colitis in rats. Dig Dis Sci 2004;49:1713–21.10.1023/B:DDAS.0000043391.64073.e4Suche in Google Scholar

9. Halliwell B. Free radicals, antioxidants, and human disease: curiosity, cause, or consequence? Lancet 1994;344:721–4.10.1016/S0140-6736(94)92211-XSuche in Google Scholar

10. Thomson A, Hemphill D, Jeejeebhoy KN. Oxidative stress and antioxidants in intestinal disease. Dig Dis 1998;16:152–8.10.1159/000016859Suche in Google Scholar PubMed

11. Lih-Brody L, Powell SR, Collier KP, Reddy GM, Cerchia R, Kahn E, et al. Increased oxidative stress and decreased antioxidant defenses in mucosa of inflammatory bowel disease. Dig Dis Sci 1996;41:2078–86.10.1007/BF02093613Suche in Google Scholar PubMed

12. Kuroki F, Iida M, Tominaga M, Matsumoto T, Kanamoto K, Fujishima M. Is vitamin E depleted in Crohn’s disease at initial diagnosis? Dig Dis 1994;12:248–54.10.1159/000171459Suche in Google Scholar

13. Kuroki F, Iida M, Tominaga M, Matsumoto T, Hirakawa K, Sugiyama S, et al. Multiple vitamin status in Crohn’s disease. Correlation with disease activity. Dig Dis Sci 1993;38:1614–8.10.1007/BF01303168Suche in Google Scholar

14. Fernandez-Banares F, Abad-Lacruz A, Xiol X, Gine JJ, Dolz C, Cabre E, et al. Vitamin status in patients with inflammatory bowel disease. Am J Gastroenterol 1989;84:744–8.Suche in Google Scholar

15. Buffinton GD, Doe WF. Depleted mucosal antioxidant defences in inflammatory bowel disease. Free Radic Biol Med 1995;19:911–8.10.1016/0891-5849(95)94362-HSuche in Google Scholar

16. Kirsner JB, Shorter RG. Recent developments in “nonspecific” inflammatory bowel disease (first of two parts). N Engl J Med 1982;306:775–85.10.1056/NEJM198204013061304Suche in Google Scholar

17. Kirsner JB, Shorter RG. Recent developments in nonspecific inflammatory bowel disease (second of two parts). N Engl J Med 1982;306:837–48.10.1056/NEJM198204083061404Suche in Google Scholar

18. Jewell DP, Patel C. Immunology of inflammatory bowel disease. Scand J Gastroenterol Suppl 1985;114:119–26.Suche in Google Scholar

19. Tuzun A, Erdil A, Inal V, Aydin A, Bagci S, Yesilova Z, et al. Oxidative stress and antioxidant capacity in patients with inflammatory bowel disease. Clin Biochem 2002;35:569–72.10.1016/S0009-9120(02)00361-2Suche in Google Scholar

20. Alzoghaibi MA, Walsh SW, Willey A, Fowler AA 3rd, Graham MF. Linoleic acid, but not oleic acid, upregulates the production of interleukin-8 by human intestinal smooth muscle cells isolated from patients with Crohn’s disease. Clin Nutr 2003;22:529–35.10.1016/S0261-5614(03)00083-9Suche in Google Scholar

21. Alzoghaibi MA, Walsh SW, Willey A, Yager DR, Fowler AA 3rd, Graham MF. Linoleic acid induces interleukin-8 production by Crohn’s human intestinal smooth muscle cells via arachidonic acid metabolites. Am J Physiol Gastrointest Liver Physiol 2004;286:G528–37.10.1152/ajpgi.00189.2003Suche in Google Scholar PubMed

22. Kruidenier L, Kuiper I, Lamers CB, Verspaget HW. Intestinal oxidative damage in inflammatory bowel disease: semi-quantification, localization, and association with mucosal antioxidants. J Pathol 2003;201:28–36.10.1002/path.1409Suche in Google Scholar PubMed

23. Nielsen OH, Ahnfelt-Ronne I. Involvement of oxygen-derived free radicals in the pathogenesis of chronic inflammatory bowel disease. Klin Wochenschr 1991;69:995–1000.10.1007/BF01645145Suche in Google Scholar PubMed

24. Grisham MB. Role of reactive oxygen metabolites in inflammatory bowel disease. Gastroenterology 1993;9:971–80.Suche in Google Scholar

25. Grisham MB. Oxidants and free radicals in inflammatory bowel disease. Lancet 1994;344:859–61.10.1016/S0140-6736(94)92831-2Suche in Google Scholar

26. Kitahora T, Suzuki K, Asakura H, Yoshida T, Suematsu M, Watanabe M, et al. Active oxygen species generated by monocytes and polymorphonuclear cells in Crohn’s disease. Dig Dis Sci 1988;33:951–5.10.1007/BF01535990Suche in Google Scholar

27. Yamada T, Grisham MB. Pathogenesis of tissue injury: role of reactive metabolities of oxygen and nitrogen. In: Targan SR, Shanahan F, editors. Inflammatory bowel disease: from bench to bedside. Baltimore: Williams and Wilkins, 1994:133–50.Suche in Google Scholar

28. Flohe L, Beckmann R, Giertz H, Loschen G. Oxygen-centered free radicals as mediators of inflammation. In: Sies H, editor. Oxidative stress. London: Academic Press, 1985:403–36.Suche in Google Scholar

29. Alzoghaibi MA, Al Mofleh IA, Al-Jebreen AM. Lipid peroxides in patients with inflammatory bowel disease. Saudi J Gastroenterol 2007;13:187–90.10.4103/1319-3767.36750Suche in Google Scholar

30. Paoletti F, Mocali A. Determination of superoxide dismutase activity by purely chemical system based on NAD(P)H oxidation. Methods Enzymol 1990;186:209–20.10.1016/0076-6879(90)86110-HSuche in Google Scholar

31. Sturniolo GC, Mestriner C, Lecis PE, D’Odorico A, Venturi C, Irato P, et al. Altered plasma and mucosal concentrations of trace elements and antioxidants in active ulcerative colitis. Scand J Gastroenterol 1998;33:644–9.10.1080/00365529850171936Suche in Google Scholar

32. Shiratora Y, Aoki S, Takada H, Kiriyama H, Ohto K, Hai K, et al. Oxygen-derived free radical generating capacity of polymorphonuclear cells in patients with ulcerative colitis. Digestion 1989;44:163–71.10.1159/000199906Suche in Google Scholar

33. Mulder TP, Verspaget HW, Janssens AR, de Bruin PA, Pena AS, Lamers CB. Decrease in two intestinal copper/zinc containing proteins with antioxidant function in inflammatory bowel disease. Gut 1991;32:1146–50.10.1136/gut.32.10.1146Suche in Google Scholar

34. Koch TR, Yuan LX, Stryker SJ, Ratliff P, Telford GL, Opara EC. Total antioxidant capacity of colon in patients with chronic ulcerative colitis. Dig Dis Sci 2000;45:1814–9.10.1023/A:1005517824877Suche in Google Scholar

35. Jentzsch AM, Bachmann H, Furst P, Biesalski HK. Improved analysis of malondialdehyde in human body fluids. Free Radic Biol Med 1996;20:251–6.10.1016/0891-5849(95)02043-8Suche in Google Scholar

36. Walsh SW, Vaughan JE, Wang Y, Roberts LJ 2nd. Placental isoprostane is significantly increased in preeclampsia. FASEB J 2000;14:1289–96.10.1096/fasebj.14.10.1289Suche in Google Scholar

37. Schmidley JW. Free radicals in central nervous system ischemia. Stroke 1990;21:1086–90.10.1161/01.STR.21.7.1086Suche in Google Scholar

38. Geerling BJ, v Houwelingen AC, Badart-Smook A, Stockbrugger RW, Brummer RJ. The relation between antioxidant status and alterations in fatty acid profile in patients with Crohn disease and controls. Scand J Gastroenterol 1999;34:1108–16.10.1080/003655299750024913Suche in Google Scholar

39. Geerling BJ, Badart-Smook A, Stockbrugger RW, Brummer RJ. Comprehensive nutritional status in patients with long-standing Crohn disease currently in remission. Am J Clin Nutr 1998;67:919–26.10.1093/ajcn/67.5.919Suche in Google Scholar

40. Beltrán B, Nos P, Dasí F, Iborra M, Bastida G, Martínez M, et al. Mitochondrial dysfunction, persistent oxidative damage, and catalase inhibition in immune cells of naïve and treated Crohn’s disease. Inflamm Bowel Dis 2009;27:76–86.Suche in Google Scholar

41. Durak I, Yasa MH, Bektas A, Kacmaz M, Cimen MY, Ozturk HS. Mucosal antioxidant defense is not impaired in ulcerative colitis. Hepatogastroenterology 2000;47:1015–7.Suche in Google Scholar

42. Bhaskar L, Ramakrishna BS, Balasubramanian KA. Colonic mucosal antioxidant enzymes and lipid peroxide levels in normal subjects and patients with ulcerative colitis. J Gastroenterol Hepatol 1995;10:140–3.10.1111/j.1440-1746.1995.tb01068.xSuche in Google Scholar

43. Levy E, Rizwan Y, Thibault L, Lepage G, Brunet S, Bouthillier L, et al. Altered lipid profile, lipoprotein composition, and oxidant and antioxidant status in pediatric Crohn disease. Am J Clin Nutr 2000;71:807–15.10.1093/ajcn/71.3.807Suche in Google Scholar

44. Simmonds NJ, Allen RE, Stevens TR, Van Someren RN, Blake DR, Rampton DS. Chemiluminescence assay of mucosal reactive oxygen metabolites in inflammatory bowel disease. Gastroenterology 1992;103:186–96.10.1016/0016-5085(92)91112-HSuche in Google Scholar

45. Thomson A, Hemphill D, Jeejeebhoy KN. Oxidative stress and antioxidants in intestinal disease. Dig Dis 1998; 16:152–8.10.1159/000016859Suche in Google Scholar PubMed